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Integrons are genetic elements containing the deter- 
minants of a site-specific recombination system [l-41. 
Integrons possess two essential elements able to mobi- 
lize and insert gene cassettes, an int gene encoding a 
site-specific recombinase belonging to the integrase 
family and its associated primary recombination site, 
attl. Captured genes, most commonly encoding 
antibiotic resistance, form part of discrete mobile 
cassettes which contain the protein-coding region and 
a recombination site, known as a 59-base element, 
located at the 3’ end of the gene. While four types of 
integrons, each with different int genes, have been 
identified to date, most of those found in clinical 
enterobacterial isolates are class I integrons. Integrons 
are located on transposons which possibly facilitate the 
rapid spread of integrons to other strains and bacterial 
species. Our previous studies, although demonstrating 
the widespread carriage of these structures, have not 
addressed the question of prevalence of integron 
carriage specifically in blood culture isolates and their 
impact on antibiotic susceptibility [1,5,6]. 
In this study we screened 278 clinical consecutive 
Gram-negative organisms isolated from blood cultures 
from different patients admitted to the University 
Hospital Dusseldorf, Germany between January and 
April 1998, for the presence of class I integrons and 
determined the size of inserted DNA, which gives 
some indication of the number of inserted genes, 
assuming one gene to be in the region of 6-700 bp. 
The presence or absence of an integron was related to 
the susceptibility to different antibiotics used at the 
institute as therapies against Gram-negative infections. 
Isolates were identified with Microscan (Dade, 
Frankfiurt, Germany) or API (bioMkrieux, Nurtingen, 
Germany) and susceptibility tested with a microbroth 
dilution method. For co-trimoxazole, a dlsk diffusion 
method was used. Methodology and interpretive criteria 
for susceptibility testing as recommended by the 
NCCLS were used throughout [7,8]. DNA for use as 
template in subsequent polymerase chain reaction pro- 
cedures was prepared from fresh overnight cultures 
grown in 5 mL of Luria Broth medium (Oxoid, 
Basingstoke, UK) as described previously [9]. 
Primers (5’-GGC ATC CAA GCA GCA AG-3’) 
and (5’-AAG CAG ACT TGA CCT GA-3’), 
previously described [lo] and complementary for con- 
served sequence (CS) regions flanking the inserted 
DNA, were used in order to identifjr the presence of 
an integron and to determine the size (if any) of 
inserted gene cassettes. Primer IntzF (5’-TCT CGG 
GTA ACA TCA AGG-3’), specific for the 3’ region 
of the integrase gene (approximately 600 bp upstream 
from the 5’CS primer site), was used in combination 
with 3’CS primer. Together, these were able to 
demonstrate the proximity of inserted gene cassettes 
to the int gene, confirming the general structure of 
the integron. The 3’CS and IntrF primer combination 
also assisted in detecting ‘empty’ integrons containing 
no inserted gene cassettes. Primers 16S806R (5’- 
GGACTACCAGGGTATCTAATCC-3’) and 2 6S8F 
(5’-AGAGTTTGATCCTGGCTCAG-3’) specific for 
the 16s RNA gene were used as positive PCR controls, 
ensuring the integrity of all sample DNA used to detect 
integrons. DNA was re-extracted from all samples 
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Table 1 Sizes of inserted gene cassettes for different species of consecutive Gram-negative blood culture isolates studied 
Bacterial species Number of isolates Number of integron-positive isolates (“h) Size of inserted gene cassettes (bp) 
Escheriihia ioli 
k7ebsiella pneumoniae 
Enterobacter cloacae 
Enterobaiter aerofenes 
Enterobaiter sakazakii 
k7ebsiella oxytota 
Protens mirabilis 
Serratia mariescens 
Serratia liqnefiiens 
Citrobaiterfreundii 
Psendomonas aenqinosa 
156 
30 
25 
10 
9 
8 
8 
7 
4 
2 
19 
26 (17) 
6 (20) 
0 
1 (4) 
1 (11) 
2 (25) 
0 
0 
0 
0 
n 
700, 1000, 1400, 1500, 1600, 1800, 1900, 2000 
700, 800, 1000, 1600 
700 
1000 
700, 1000 
- 
- 
- 
- 
- 
- 
giving no amplification product with the 16s RNA- 
specific primer set, and amplification procedures were 
repeated in order to validate the negative result. PCR 
amplification conditions used were as described 
previously [lo]. All 278 isolates included in the study 
were shown to be unrelated using pulsed-field gel 
electrophoresis, other isolates being excluded [I 11. 
Overall, from 378 consecutive blood culture iso- 
lates comprising 11 different Gram-negative species, 
13% of isolates were shown to carry integrons which 
were detected in Klebsiella pneumoniae (2/8), K. oxytoca 
(6/30), Escherichia coli (26/156), Enterobacter sakazakii 
(1/9) and Enterobacter cloacae (1/25). All other species 
were integron negative (Table 1). Two Esrhevichia coli 
isolates possessed two integrons with different-sized 
inserted regions (1000/1300 bp and 10 000/1800 bp 
respectively), all other isolates possessing single integron 
structures with inserted regions varying from 700 to 
2000 bp, demonstrating the heterogeneity of inserted 
sequence sizes. No ‘empty’ integron structures were 
detected. All detectable integrons were adjacent to an 
integrase-encoding gene, as was demonstrated using 
the Int2F and 3’CS primer combination set. 
To assess the effect of integron carriage on the 
susceptibility profile of these unrelated routine blood 
culture isolates, we compared MIC data of integron- 
positive strains to those obtained from integron-nega- 
tive strains. To do this we pooled data only from the 
five species in which integrons were detected. The 
carriage of an integron is significantly associated with a 
decrease in susceptibility to all of the seven antibiotics 
tested (Table 2), with MICq(1 values for the amino- 
glycosides and quinolones being three dilution steps 
higher in integron-positive isolates and one dilution 
step higher for the p-lactam compounds tested. Seventy 
per cent (25/36) of integron-positive isolates were 
resistant to co-trimoxazole, compared to only 6% 
(15/342) of integron-negative isolates, suggesting co- 
trimoxazole to be a fairly useful phenotypic marker for 
integron carriage. 
While we have previously demonstrated integrons 
to be widely distributed among randomly selected 
Gram-negative nosocomial isolates from different Euro- 
pean hospitals [5,6], this is the first report to investigate 
the prevalence of these genetic structures specifically 
within consecutive blood culture isolates. The different- 
Table 2 The MICw range of values, and percentage susceptible (S), intermediate (I) and resistant (R) for each antibiotic, 
grouped in accordance with integron status, for each isolate studied 
Antibiotics 
Gentamicin 
Tobramycin 
Ciprofloxacin 
Ampicillin 
Ceftazidime 
Aztreonam 
Co-trirnoxazoie 
Integron-positive isolates (n=36) Integron-negative isolates (n=  192) 
MICru MIC9o 
(mg/L) (range) % S  % I  % R  (mg/L) (range) u/o S % I  D/u R P-value 
32 (>6.W.12) 80 5 15 4 (>64-0.12) 96 2 2 10.01 
32 (>6.1-0.12) 75 15 10 4 (>64-0.12) 92 3 5 <0,01 
4 (>8 to 0.015) 77 3 20 0.5 (8 to <0.015) 97 I 1 10.01 
128 (>I28 to 2.0) 20 12 78 64 (2128 to <0.03) 37 10 53 <0.01 
64 (>64 to <0.03) 77 4 19 32 (>64 to <0.03) 85 7 8 <0.01 
16 (>64 to <0.03) 78 7 15 8 (>64 to <0.03) 97 1 2 CO.01 
Not done 30 - 70 Not done 94 - 6 10.01 
7 
The P-value (Pearson chi-squared test) indicates the statistical difference between the susceptibility in terms of S, I and R percentage values 
between the two groups. Only species in which integrons were detected were included in this analysis. NCCLS interpretive criteria are 
used throughout [ S ] .  
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sized cassettes inserted between CS regions found 
among the strains studied demonstrate the variable 
nature of these structures, presumably reflecting differ- 
ences in the number and type of inserted gene cassettes. 
Additionally, many inserted regions of DNA, indistin- 
guishable with respect to size, were detected in isolates 
from different species or from isolates of the same 
species shown to be unrelated by genotyping, sug- 
gestive of horizontal gene transfer. 
An integron-positive status was significantly 
associated with reduced susceptibility to each of the 
antibiotics tested. For aminoglycoside compounds, this 
is hardly surprising, since many aminoglycoside resist- 
ance genes have been reported within integron struc- 
tures [l]. However, the negative impact of integron 
carriage on susceptibility to cefiazidime, aztreonam 
and ciprofloxacin, resistance to which has never been 
reported as being integron-encoded, is curious. 
Decreased susceptibility to p-lactams in integron- 
positive strains is most likely due to an association of p- 
lactamase genes within integrons or integron-carrying 
plasmids, several of which have been reported as being 
integron encoded [l]. However, genes encoding 
resistance to extended-spectrum p-lactams, such as 
cefiazidlme and aztreonam, have never been reported 
as being integron-encoded, suggesting an association 
between integrons and extended-spectrum p-lactamase 
carriage, perhaps via a common host plasmid. Resist- 
ance to quinolone compounds is derived through 
chromosomal point mutations rather than transferred 
by mobile genetic elements [12]. Therefore, integron 
structures may be associated, perhaps by carriage on a 
common host plasmid, with other genetic structures 
mediating quinolone resistance, such as mutator plas- 
mids [13,14] or genes affecting permeability or drug 
efflux [15]. 
Clearly, integron carriage is associated with reduced 
susceptibility to several different classes of antibiotic 
used in empirical Gram-negative therapies. This, com- 
bined with the clear demonstration that these structures 
are prevalent among unrelated blood culture isolates of 
different species, suggests that integrons play a role 
in the evolution of multiresistance in Gram-negative 
isolates. 
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